Achieve Life Sciences Announces Proposed Underwritten Public Offering
SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty…
Pharmaceuticals, Biotechnology and Life Sciences
SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty…
Omnicom cross-agency collaboration to drive technology-led, innovative launch strategy Partnership brings together promising science, top-tier talent, and advanced technologies to…
WAYNE, Pa., June 26, 2025 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing…
Smoking, the leading cause of preventable death and disease, continues to affect nearly 29 million adults in the U.S. alone…
BERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and…
Company to host a conference call to discuss results at 8:00am EDT on June 30, 2025 Boca Raton, Florida, June…
Introducing Ice Cream Man, Skywalker OG Gold Edition, Red Velvet, Gold Cash Gold Edition, and Jedi BreathMADISON, Wis., June 26,…
The new branding showcases the Company’s innovative vision for the future and mission to redefine the retina experienceBEDFORD, Mass., June…
Percheron Therapeutics obtains exclusive worldwide rights to Hummingbird Bioscience’s anti-VISTA mAb for further clinical development Hummingbird Bioscience stands to receive…
Company to host Investor Webcast on Thursday, June 26, 2025, at 8:30 am E.T.GAITHERSBURG, Md., June 25, 2025 (GLOBE NEWSWIRE)…